No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CEL-SCI Q4 EPS $(0.09) Beats $(0.11) Estimate
Express News | CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer
Press Release: CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer
CEL-SCI | 10-K: FY2024 Annual Report
CEL-SCI Completes $5 Million 'Best Efforts' Stock Sale
12 Health Care Stocks Moving In Monday's Pre-Market Session